Potter, Gail E.
Callier, Viviane
Shrestha, Biraj
Joshi, Sudhaunshu
Dwivedi, Ankit
Silva, Joana C.
Laurens, Matthew B.
Follmann, Dean A.
Deye, Gregory A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
https://doi.org/10.1371/journal.pmed.1001685
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
https://doi.org/10.1016/s0140-6736(15)60721-8
Documents that mention this clinical trial
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Documents that mention this clinical trial
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model
https://doi.org/10.1371/journal.pmed.1001891
Funding for this research was provided by:
National Institutes of Health (HHSN261201500003I)
National Institutes of Health (U01AI112367)
National Institutes of Health,United States (R01 AI141900)
National Institutes of Health,United States (R01 AI141900)
National Institutes of Health
Article History
Received: 19 September 2023
Accepted: 22 November 2023
First Online: 19 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.